Susquehanna International Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Sell |
|
|||||
|
2025
Q1 | $2.21M | Buy |
|
|||||
|
2024
Q4 | $1.85M | Buy |
|
|||||
|
2024
Q3 | $536K | Sell |
|
|||||
|
2024
Q2 | $861K | Buy |
|
|||||
|
2024
Q1 | $687K | Buy |
|
|||||
|
2023
Q4 | $241K | Sell |
|
|||||
|
2023
Q3 | $579K | Buy |
|
|||||
|
2023
Q2 | $923K | Sell |
|
|||||
|
2023
Q1 | $2.9M | Buy |
|
|||||
|
2022
Q4 | $968K | Sell |
|
|||||
|
2022
Q3 | $1.84M | Buy |
|
|||||
|
2022
Q2 | $393K | Sell |
|
|||||
|
2022
Q1 | $1.16M | Sell |
|
|||||
|
2021
Q4 | $2.15M | Buy |
|
|||||
|
2021
Q3 | $1.2M | Sell |
|
|||||
|
2021
Q2 | $2.42M | Buy |
|
|||||
|
2021
Q1 | $1.16M | Buy |
|
|||||
|
2020
Q4 | $514K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $358K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $287K | Sell |
|
|||||
|
2019
Q2 | $783K | Buy |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $508K | Buy |
|
|||||
|
2015
Q2 | $356K | Sell |
|
|||||
|
2015
Q1 | $335K | Sell |
|
|||||
|
2014
Q4 | $859K | Buy |
|
|||||
|
2014
Q3 | – | Hold |
|